Read + Share
Meenan J, Hall R, Badle S, Chatterjee B, et al. Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in
sickle cell disease: The experience so far. Transfusion 2022;62:546-550.
PMID: 35092617
|
 |
|
Meenan J, Hall R, Badle S, Chatterjee B, et al. Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in
sickle cell disease: The experience so far. Transfusion 2022;62:546-550.
PMID: 35092617
|
|
|
|